Small Molecule Activators of the Insulin Receptor: Potential New Therapeutic Agents for the Treatment of Diabetes Mellitus

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|9|24|2231-2242

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.9, Iss.24, 2002-12, pp. : 2231-2242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhaled insulin – a new therapeutic option in the treatment of diabetes mellitus

By Díez Juan José   Iglesias Pedro  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 2, 2003-02 ,pp. : 191-200

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Glucokinase Activators as Glucose Lowering Agents: A New Paradigm for Diabetes Therapy

By  

Current Medicinal Chemistry, Vol. 13, Iss. 15, 2006-06 ,pp. : 1839-1843

Bentham Science Publishers

Access to resources Recommend Favorite

Glucokinase activators as new type 2 diabetes therapeutic agents

By Sarabu Ramakanth   Berthel Steven J   Kester Robert F   Tilley Jefferson W  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 7, 2008-07 ,pp. : 759-768

Informa Healthcare

Access to resources Recommend Favorite

Glucagon-Like Peptide-1 Synthetic Analogs: New Therapeutic Agents for Use in the Treatment of Diabetes Mellitus

By  

Current Medicinal Chemistry, Vol. 10, Iss. 22, 2003-11 ,pp. : 2471-2483

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetes Beyond Insulin: Review of New Drugs for Treatment of Diabetes Mellitus

By  

Current Drug Discovery Technologies, Vol. 4, Iss. 1, 2007-01 ,pp. : 39-47

Bentham Science Publishers

Access to resources Recommend Favorite